Brookfield Corporation (BN) Stock Price & How to Invest

Brookfield Corporation sits at the top of the Brookfield group and reports through three pillars. Asset management runs through its roughly 73% interest in Brookfield Asset Management, whose fee-bearing capital reached ~$614 billion in the first quarter of 2026, up ~12% year over year on ~$67 billion of year-to-date fundraising that included a ~$40 billion investment mandate from UK annuity provider Just Group. Wealth solutions is the annuity and pension-risk-transfer business (Brookfield Wealth Solutions, built from American National, Argo Group and American Equity Life) that gathers policyholder money and invests it alongside Brookfield's own funds. The third pillar is the operating businesses, held partly through the listed affiliates: Brookfield Renewable (BEP/BEPC), Brookfield Infrastructure (BIP/BIPC), Brookfield Business Partners (BBU/BBUC) and a wholly owned real estate book that includes Canary Wharf, Brookfield Place and Ala Moana Center. Bruce Flatt has run the company since 2002, and the December 2022 reorganisation is what created the BN-versus-BAM split: BN kept the balance sheet and the carried interest, BAM was carved out as the pure-play, high-payout manager.

The investment picture is a valuation puzzle as much as a business question. Shares closed at ~$44 on August 7, 2026 for a market capitalisation of ~$101 billion against revenue of ~$79 billion over the trailing twelve months, yet net income attributable to shareholders was only ~$1.2 billion, which puts the reported P/E near ~86x. That gap exists because consolidation drags in revenue and assets Brookfield does not own outright, and because depreciation on long-lived infrastructure suppresses accounting profit. Management therefore steers investors to distributable earnings, ~$1.6 billion or ~$0.66 per share in the first quarter of 2026, of which ~$1.4 billion came before realizations. The dividend is deliberately small, ~$0.26 per share annualised for a yield near ~0.6%, because capital is retained for buybacks and new commitments. A structural simplification approved by shareholders on July 16, 2026 will fold Brookfield Wealth Solutions into a new parent that keeps the BN ticker on both exchanges, exchanging shares one for one and expected to close by year end.

The reported financials are hard to underwrite: consolidation pulls in revenue and debt from entities BN does not fully own, so ~$79 billion of trailing revenue and ~$1.2 billion of attributable net income describe the same company, and an investor has to accept management's distributable earnings framing to value it. Leverage sits mostly at the asset level in non-recourse form, which limits contagion but leaves refinancing exposed to long rates and credit spreads across hundreds of separate structures. The office and retail real estate book has already required writedowns and remains the least liquid piece. The insurance pillar introduces a different risk set entirely: spread compression if rates fall, reserve assumptions on long-dated annuities, and regulators in multiple jurisdictions reviewing private-capital ownership of annuity liabilities. Carried interest and realization gains depend on exit markets that shut for long stretches, and BN's ~1.8 beta means the stock has historically fallen harder than the index when they do.

10 analysts publish price targets on BN, averaging $54.20 against a $44.08 price as of August 2026, or +23.0%. The published targets run from $31.00 to $61.00, a moderate spread, and the ratings split 10 buy, 0 hold, 1 sell. Over the last six months there have been 4 raises and 3 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full BN forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Brookfield Corporation. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Fee-bearing capital and carried interest at BAM. BAM's fee-bearing capital of ~$614 billion at the end of the first quarter of 2026 grew ~12% year over year, and BN captures ~73% of that fee stream plus essentially all of the accumulated carried interest from the older fund vintages. The most optimistic published target, $61.00, assumes this works close to its best case.

The case against. The reported financials are hard to underwrite: consolidation pulls in revenue and debt from entities BN does not fully own, so ~$79 billion of trailing revenue and ~$1.2 billion of attributable net income describe the same company, and an investor has to accept management's distributable earnings framing to value it. The most pessimistic target, $31.00, is roughly what BN is worth if this bites instead.

Read the full bull and bear case on BN, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Brookfield Corporation's investor relations page or your broker.

• Share price / market cap: ~$44 per share, ~$101 billion (Aug 7, 2026 close)
• Revenue (TTM): ~$79 billion
• Net income attributable (TTM): ~$1.2 billion, a reported P/E near ~86x
• Distributable earnings (Q1 2026): ~$1.6 billion, ~$0.66 per share (~$1.4 billion before realizations)
• Fee-bearing capital at BAM: ~$614 billion, up ~12% year over year
• Dividend: ~$0.26 per share annualised, ~0.6% yield

First quarter 2026 revenue was ~$18.6 billion with net income of ~$1.04 billion, against ~$215 million a year earlier, so the year-over-year jump reflects mark movements more than a step change in operations. The reported P/E near ~86x is not a like-for-like multiple: depreciation on infrastructure and the share of consolidated profit belonging to outside partners both sit between revenue and attributable earnings. Second quarter 2026 results are scheduled for August 13, 2026, with consensus around ~$0.65 per share before the release.

Other names that sit close to BN: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get BN exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so BN sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where BN fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

BN is the compounding parent of the Brookfield complex, and the trade-off is that its economics arrive through carried interest, insurance spread and asset-level equity rather than through clean reported earnings.

Whether BN is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is BN a buy or a sell?, and where the stock could go from here in the BN stock forecast.

For income investors, whether BN pays a dividend and how the payout looks is covered in does BN pay a dividend? And to weigh BN against a peer, read the full side-by-side comparisons: BN vs BX and BN vs KKR.